1 , 2 Constipation is reported in 4% to 12% of patients and occurs more frequently in individuals with obesity, likely due to the use of higher doses
A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the GLP-1 Analogues market sector across the globe
Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with type 2 diabetes and obesity or overweight and adults with severe obesity and established cardiovascular disease, and the timeline for future readouts, presentations and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
Dose adjustments of these agents are likely to be necessary under medical supervision
When considering injectable-based combination therapy, GLP-1RAs are preferred over basal insulin (RCT, General) [47]
Another study showed that semaglutide protected against A 25-35 in SH-SY5Y cells by enhancing autophagy (200)